Complications of HIV in perinatally infected adolescents and young adults in resource-poor settings Philippa Musoke MBChB PhD Department of Paediatrics.

Slides:



Advertisements
Similar presentations
HYPnet Late presentation of vertically transmitted HIV infection in adolescence A Judd 1, R Ferrand 2,3, E Jungmann 2, C Foster 4, H Lyall 4, Brian Rice.
Advertisements

International AIDS Society, Industry Liaison Forum, Montreal, 8 th February 2009 Paediatric HIV Research: Status, priorities and ethical considerations.
Tuberculosis incidence and risk factors among adult patients receiving HAART in Senegal: a 7-year cohort study Assane DIOUF et al. IRD/UMR 145 CRCF, CHNU.
Cognitive, neurological and adaptive behaviour functioning among children with perinatally-acquired HIV infection Anita Shet, Smitha Holla, Vijaya Raman,
Monica Gandhi MD, MPH Associate Professor and Women’s HIV Clinic provider, HIV/AIDS Division San Francisco General Hospital/ UCSF Safe Poz Love, U.S. Positive.
The new guidelines Dr Francois Venter Reproductive Health and HIV Research Unit University of the Witwatersrand Feb 2010.
High prevalence of PLIN gene & Metabolic risk factors among Children initiating Antiretroviral therapy in south India P. Chandrasekaran, A. Shet, K. Ramesh,
Washington D.C., USA, July 2012www.aids2012.org The value of universal TB screening with GeneXpert MTB/RIF in pre-ART patients in Harare L. Mupfumi.
P1060 commentary Philippa Musoke MBChB Makerere University –Johns Hopkins University Research Collaboration, Kampala Uganda.
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
A case series of ART-associated gynaecomastia reported to the National HIV & TB Healthcare Workers (HCW) hotline Christine Njuguna. Division of Clinical.
Graeme Meintjes Department of Medicine, University of Cape Town HIV Service, GF Jooste Hospital TB-IRIS Research priorities and update from Kampala workshop.
Late-outcomes of TB-IRIS William Worodria, MBChB, MMed, PhD Senior EDCTP Fellow Infectious Disease Institute, Kampala, Uganda Mulago Hospital & Complex,
Most deaths among children enrolled in two program settings in Cambodia occur within the first 6 months after enrolment. Early mortality rates were more.
ICS in COPD – A Risk Factor for CAP? Rate of pneumonia in ICS Studies
Tuberculosis in Children and Young Adults
HIV Science Update: From Rome to Addis – Biomedical Prevention Elly T Katabira, FRCP Department of Medicine Makerere University College of Health Sciences.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 20.
Unit 5: IPT Isoniazid TB Preventive Therapy
Pediatric HIV Care & Treatment in Uganda A Five-Day Training Course For Health Professionals.
Moving Towards Targeted HIV Testing In Older Children Bandason T, McHugh G, Dauya E, Mungofa S, Kranzer K, Ferrand RA BRTI ZIMA Conference - August 2014.
Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases National Heart, Lung, and Blood Institute February, 2012.
Presenter : Dr T. G. Nematadzira on behalf of The IMPAACT PROMISE 1077BF/1077FF Team Efficacy and Safety of Two Strategies to Prevent Perinatal HIV Transmission.
Matthew Fox Center for Global Health & Development Department of Epidemiology Boston University July 17, 2011 The first step is admitting you have a problem.
Johns Hopkins Center for Tuberculosis Research
Long term follow up of the UK and Ireland paediatric cohort as teenagers transition to adult services Ali Judd, 1 Caroline Foster, 2 Caroline Sabin, 3.
Background There is uncertainty regarding the frequency, predictors, and outcomes of IRIS events Prior studies on IRIS have been limited to convenience.
Case Series of HIV-infected children with Bacillus Calmette-Guérin Vaccine Related Lymphadenopathy in Lilongwe, Malawi John Midturi Kazembe, PN., Schutze,
C Foster, A Judd, H Lyall, T Dunn, K Doerholt, P Tookey, D Gibb For Young people with perinatally acquired HIV: a Transitioning UK cohort.
Older and wiser: continued improvements in clinical outcome and highly active antiretroviral therapy (HAART) response in HIV-infected children in the UK.
Data from the Collaborative HIV Paediatric Study (CHIPS) Reports up to March 2009* * Numbers are based on reports received rather than children seen to.
Late and Low Compliance with Hepatitis B Serology Screening among HIV-infected Patients in a Resource-limited Setting: An Issue to Improve HIV Care Abstract.
Transition Program of HIV-infected adolescents to Adult HIV care in Buenos Aires, Argentina S. Arazi Caillaud 1, D. Mecikovsky 1, A.Bordato.
HIV/renal studies (CHIC) Baseline renal function as predictor of HIV/renal disease progression –Death, opportunistic infection –Severe chronic kidney disease.
Impact of Highly Active Antiretroviral Therapy on the Incidence of HIV- encephalopathy among perinatally- infected children and adolescents. Kunjal Patel,
Edward Mills PhD, Associate Professor, Faculty of Health Sciences University of Ottawa AIDS Mortality Among Men in Africa: An overview of the evidence.
TREATMENT OF SERO-DISCORDANT COUPLES: IMPLICATIONS FOR YOUNG PEOPLE JJ KUMWENDA (FRCP-UK)
Cape Town 17/07/09 Provider Initiated HIV Screening for Children Attending Nutritional Ward in KTH Operations research proposal Presented by Tamadur Elnour.
The Effectiveness of generic Highly Active Antiretroviral Therapy for the treatment of HIV infected Ugandan children Presenter: Linda Barlow-Mosha MD,
The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children Heidi M.
Data from the Collaborative HIV Paediatric Study (CHIPS) Reports up to March 2006* *Numbers are based on reports received rather than children seen to.
Integrating research into care: working with children and adolescents Mark Cotton Children’s Infectious Diseases Clinical Research Unit.
Lipid profile in children randomized to immediate versus deferred nevirapine-based antiretroviral therapy in the PREDICT study Kanjanavanit S, Puthanakit.
Dr Pulin Kumar Gupta Associate Professor Department of Medicine Incharge HIV/ART Centre PGIMER, Dr RML Hospital NEW DELHI INDIA.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
Tuberculosis in Children and Young Adults
Exposure and response to highly active antiretroviral therapy (HAART) in ART naïve children in the UK and Ireland Judd A. 1, Lee K.J. 1, Duong T. 1, Walker.
A Call to Action Children – The missing face of AIDS.
RISK FACTORS FOR MALNUTRITION
Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.
Post-discharge chemoprevention of malaria in transfused children; a randomized trial in Uganda & Kenya R Idro, R Opoka, A Dhabangi, F TerKuile, and K Phiri.
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection The INSIGHT START Study Group Ben Andres Oct 15, 2015.
Problems of HIV Infection in the HAART Era Akihiko Suganuma M.D. Tokyo Metropolitan Komagome Hospital Department of Infectious Diseases.
Diego Ripamonti - Malattie Infettive - Bergamo Simposio HOT TOPICS Hot topics in HIV 2015.
ART was initiated when indicated by WHO and national guidelines
ADVERSE OUTCOMES OF TREATING HIV-TB
Pregnancy and living with HIV
The role of secondary prophylaxis in the management of HIV-VL co-infection: 7-years experience from West Bengal Prof. Rama Prosad Goswami, Department.
Tolerability of Isoniazid Preventive Therapy (IPT) in an HIV infected cohort
Providing ARVs to children in resource limited settings
Berket Yemane, Melaku Umeta, Fikre Enquselassie, Wondwossen Amogne
Predictors of antiretroviral treatment associated tuberculosis in Ethiopia: a nested case control study Nebiyu Mesfin, MD.
Intensification with INSTI
The use of cotrimoxazole prophylaxis in the context of HIV infection
Research Institute for Health Sciences, Chang Mai University, Thailand
Juan Gonzalez Perez AIDS Healthcare Foundation
11/23/2018 National University of Lesotho, Southern Africa
Tolerability of Isoniazid Preventive therapy Among HIV infected Cohort in Nigeria Folajinmi Oluwasina Strategic Information Unit AIDS Healthcare Foundation,
Tuberculosis Global Epidemiology
Intensification with INSTI
Presentation transcript:

Complications of HIV in perinatally infected adolescents and young adults in resource-poor settings Philippa Musoke MBChB PhD Department of Paediatrics and Child Health College of Health Sciences, School of Medicine Makerere Unversity Kampala Uganda and MUJHU Research Collaboration

Outline Complications of HIV infection in adolescents o Malnutrition o Chronic lung disease o Tuberculosis o Lipodystrophy

Malnutrition and HIV infection  Most HIV infected children are malnourished Median wt- and ht-for-age z-score <-2  In 30 different studies of children on ART (Sutclife)  30 – 50% of children hospitalized with severe acute malnutrition (SAM) are HIV+ (Bachou H)  Mortality of children with HIV and SAM is 4 times higher than those with SAM alone (30% vs 8%) (Fergusson P)  Severe pneumonia and SAM were risk factors for death in hospitalized children (Preidis GA J Pediatr 2011) Fergusson P, et al Trans R Soc Trop Med Hyg 2008; Sutcliffe et al CG, Bachou H et al. Nutr J 2006,

Adolescents physical changes  Stunted and wasted  Dermatological changes  Puberty delayed  Complications from ART

STUNTING in HIV infected sibling

Severe malnutrition post ART  ARROW trial – Compared children who were hospitalized with SAM ( both edematous and non-edematous types) and those not hospitalized  39/1207 (3.2%) were hospitalized (20 with edema)  Median days after ART initiation = 27 days Age median 6 years (3-17 years)  Children with advanced disease n =220 (CD4% & WAZ<-3 SD) 7.3% (95% CI 3.8–10.7) kwashiorkor (K) 3.2 % (95% CI 1.2–6.1) marasmus (M)  Mortality at 24 wks - 32% marasmus; 20% kwashiorkor - compared to 1.7 % for non hospitalized children Prendergast A et al AIDS 2011

Chronic Lung disease in adolescents  HIV infected ART naïve adolescents  N=116 (Zimbabwe)  Mean Age: 14 years years  43% male  Chronic cough 66%  >40% had hypoxia at rest  Pathology: small airway disease associated with bronchiectasis Ferrand RA et al CID 2011

Increase incidence of Tuberculosis disease in HIV infected children  Cohort of south African children randomized to INH or placebo(548 HIV+ and 804 HIV- infants) (Smith) 121 TB cases /1000 child-years (CI ) HIV+ 41 TB cases/1000 child-years (CI 31-52) HIV –  No benefit of INH prophylaxis  IRIS (20-30% of children on ART) 29% of IRIS events in children were TB –Uganda (Orikiriiza) 71% % of IRIS events in children were TB –S.Africa (Mahdi) Majority BCG adenitis Mahdi SA et al NEJM 2011; Orikiriiza J et al AIDS 2009; Smith K et al AIDS 2009

Prevalence of Immune Reconstitution Syndrome  Cohort of 162 Ugandan children on ART  38% ( CI 31-36) developed IRIS  Median Age 6 years (IQR years)  Tuberculosis was the most common event=29%  Others - pruritic papular eruptions (PPE), candida and pneumonia  Factors associated with IRIS Male sex OR 2.96 ( ) Pre-ART CD4% OR 4.39 ( ) CD8+ < 1000 cells/ul OR 4.56 ( ) Cough(current)OR 4.30 ( ) Orikiriiza J et al AIDS 2010

Lipodystrophy in Resource-Limited Settings  Thailand 90 HIV+ children on ART (NNRTI) Lipodystrophy – 9%, 47% and 65% at 48, 96 and 144 weeks 11% dyslipidemia  India 52 HIV + children ( 25 ART – non PI, 27 not on ART) Only 4 had cholesterol 2 lipoatrophy, 3 triglycerides ( follow up 3 months)  Brazil 30 children (30% on PI) median duration on ART 28 mths 53% lipodystrophy, 60% dyslipidemia Aurpibul L et al Antivir Ther 2007; Parakh A Indian J Pediatr; Sarni RO et al J Pediatr

Lipodystrophy on ART  364 children enrolled in a cross sectional study, Uganda Median age was 8 years ( range 2-18) Prevalence of fat redistribution was 27%  Only 29% of them also had hyperlipidaemia Prevalence of hyperlipidemia was 34%  Factors associated with fat redistribution Tanner stage >2, age > 5yrs and use of d4T regimen J Int AIDS Soc. 2012

THANK YOU